(Q36491906)

14 August 2017

1 reference

title

Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach (English)

1 reference

14 August 2017

Harrison ML

1

1 reference

14 August 2017

Goldstein D

series ordinal

2

1 reference

14 August 2017

publication date

1 June 2006

1 reference

Internal Medicine Journal

14 August 2017

published in

1 reference

14 August 2017

volume

36

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

367-377

1 reference

Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Management of malignant gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

The effect of surgery and grade on outcome of gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Biology of gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Results of Hepatic Resection for Sarcoma Metastatic to Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Diagnosis of gastrointestinal stromal tumors: A consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01077.X

10.1111/J.1445-5994.2006.01077.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference